MedGenome Awarded With the Bio-Excellence Award for the Year 2016 by Government of Karnataka

BANGALORE, February 17, 2016 /PRNewswire/ --

MedGenome has been awarded the 'Emerging Company of the Year' in the category of 'Bioinformatics and Systems Biology' by the Government of Karnataka under its Bio-Excellence Awards category in a glittering ceremony held in Bangalore on February 10, 2016. These awards, given every year, recognize the contribution of emerging and established biotech companies and individuals for their outstanding achievements in the field of biotechnology.

The award function was presided over by Mr K.J. George, Minister for Bengaluru Development, V. Manjula, IAS, Principal Secretary to Government and Dr Murali, President, The Association of Biotechnology Led Enterprises (ABLE).

"Deriving actionable insights from genomics data through effective interpretation is the important challenge that companies globally are trying to tackle ," said Mr Sam Santhosh, Chairman, MedGenome. "This recognition is an encouragement for MedGenome to continue that journey and be a global player in advancing precision medicine ."

MedGenome Bangalore facility is the highest throughput next-generation sequencing facility in South-East Asia. The firm has developed powerful analytical and algorithmic pipelines that can interpret genomics data and derive useful insights, for both diagnostic and research purposes, from the huge amount of data generated through sequencing. MedGenome has also developed analysis and interpretation tools and databases that are proprietary and of global standards. This has enabled the company to offer genomics solutions and platforms such as OncoPept for Cancer Immunotherapy and Integrated Genomics Platform for commercial research.

"The powerful interpretation tools coupled with our domain knowledge enables us to provide very accurate and useful insights to our clinicians through genetic tests, for making a treatment choice or decide on disease management techniques for their patients," suggested Mr Girish Mehta, CEO, MedGenome, India.

MedGenome is also the only company in the country to offer non-invasive prenatal test in a facility in India, in collaboration with its technology partner in the US.

About MedGenome  

MedGenome is a genomics-based diagnostics and research company delivering the best of healthcare by decoding genetic information contained in an individual's genome. It is the first mover and market leader in genomics-based diagnostics and research from India. MedGenome has worked with thousands of doctors, hospitals, and patients across India by applying Next-generation Sequencing (NGS) techniques to large disease cohorts in cancer, eye and neurological disorders, diabetes, cardiovascular diseases and rare cancers. For more information, visit at http://www.medgenome.com

Media Contact:
Sunil Nair
[email protected]
+919820691960
Concept Public Relations India Limited